SMTL ID : 3w69.1 (1 other biounit)

Crystal structure of human mdm2 with a dihydroimidazothiazole inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x LTZ: (5R,6S)-2-[((2S,5R)-2-{[(3R)-4-acetyl-3-methylpiperazin-1-yl]carbonyl}-5-ethylpyrrolidin-1-yl)carbonyl]-5,6-bis(4-chlorophenyl)-3-isopropyl-6-methyl-5,6-dihydroimidazo[2,1-b][1,3]thiazole(Non-covalent)

LTZ.1: 12 residues within 4Å: Chain A: L.32, L.35, G.36, I.39, M.40, Y.45, Q.50, V.53, V.71, H.74, I.77, Y.78 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:I.39, A:Y.45, A:V.53, A:V.71, A:I.77 Hydrogen bonds: A:Q.50 Halogen bonds: A:Y.78

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 4 residues within 4Å: Chain A: E.73, H.74, R.75, K.76 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:H.74, A:R.75, A:K.76 Water bridges: A:K.76, A:K.76 Salt bridges: A:R.75, A:K.76

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Miyazaki, M. et al., Synthesis and evaluation of novel orally active p53-MDM2 interaction inhibitors. Bioorg.Med.Chem. (2013)

Release Date

2013-06-05

Peptides

E3 ubiquitin-protein ligase Mdm2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

E3 ubiquitin-protein ligase Mdm2

Related Entries With Identical Sequence